PharmX Technologies (PHX.AX) Earnings Analysis
PharmX Technologies (PHX.AX) next reports earnings on 2026-09-01. Trailing P/E 200.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PHX.AX next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
PHX.AX earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
PHX.AX valuation and analyst view
| Trailing P/E | 200.00 |
|---|---|
| Trailing EPS | -0.00198 AUD |
| Price / book | 3.84 |
| Dividend yield | 0.00% |
| Market cap | 0.07B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PharmX Technologies (PHX.AX)'s next earnings date?
PharmX Technologies is next scheduled to report on 2026-09-01.
What is PHX.AX's current P/E ratio and EPS?
PHX.AX trades at a trailing P/E of 200.00 on trailing EPS of -0.0019817214825520527 AUD.
What do analysts rate PHX.AX?
PHX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.